1. Socio-ethical challenges and opportunities for advancing diversity, equity, and inclusion in digital medicine.
- Author
-
Paccoud I, Leist AK, Schwaninger I, van Kessel R, and Klucken J
- Abstract
Digitalization in medicine offers a significant opportunity to transform healthcare systems by providing novel digital tools and services to guide personalized prevention, prediction, diagnosis, treatment and disease management. This transformation raises a number of novel socio-ethical considerations for individuals and society as a whole, which need to be appropriately addressed to ensure that digital medical devices (DMDs) are widely adopted and benefit all patients as well as healthcare service providers. In this narrative review, based on a broad literature search in PubMed, Web of Science, Google Scholar, we outline five core socio-ethical considerations in digital medicine that intersect with the notions of equity and digital inclusion: (i) access, use and engagement with DMDs, (ii) inclusiveness in DMD clinical trials, (iii) algorithm fairness, (iv) surveillance and datafication, and (v) data privacy and trust. By integrating literature from multidisciplinary fields, including social, medical, and computer sciences, we shed light on challenges and opportunities related to the development and adoption of DMDs. We begin with an overview of the different types of DMDs, followed by in-depth discussions of five socio-ethical implications associated with their deployment. Concluding our review, we provide evidence-based multilevel recommendations aimed at fostering a more inclusive digital landscape to ensure that the development and integration of DMDs in healthcare mitigate rather than cause, maintain or exacerbate health inequities., Competing Interests: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: J.K. declares an unpaid role in the European Taskforce for Harmonized Evaluation of Digital Medical Devices. A.L. has served on advisory boards with Roche (remunerated). None of the other authors report conflicts of interest., (© The Author(s) 2024.)
- Published
- 2024
- Full Text
- View/download PDF